BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2020 11:33:23 AM | Browse: 692 | Download: 1118
Publication Name World Journal of Gastroenterology
Manuscript ID 57229
Country/Territory Spain
Received
2020-06-09 10:05
Peer-Review Started
2020-06-09 10:06
To Make the First Decision
Return for Revision
2020-07-29 00:05
Revised
2020-08-12 09:30
Second Decision
2020-09-16 12:11
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-09-17 04:53
Articles in Press
2020-09-17 04:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2020-10-09 03:07
Publish the Manuscript Online
2020-10-14 11:33
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Observational Study
Article Title Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study
Manuscript Source Unsolicited Manuscript
All Author List Arantza Sanvisens, Inmaculada Rivas, Eva Faure, Néstor Espinach, Anna Hernandez-Rubio, Xavier Majó, Joan Colom and Robert Muga
ORCID
Author(s) ORCID Number
Arantza Sanvisens http://orcid.org/0000-0001-6269-5491
Inmaculada Rivas http://orcid.org/0000-0003-2633-5530
Eva Faure http://orcid.org/0000-0002-5056-0888
Néstor Espinach http://orcid.org/0000-0002-5726-5435
Anna Hernandez-Rubio http://orcid.org/0000-0001-8612-7827
Xavier Majó http://orcid.org/0000-0003-4338-6014
Joan Colom http://orcid.org/0000-0001-6861-7865
Robert Muga http://orcid.org/0000-0001-6301-431X
Funding Agency and Grant Number
Funding Agency Grant Number
the Ministry of Science, Innovation and Universities, Carlos III Health Institute (ISCIII), European Fund for Regional Development (FEDER), Network for Cooperative Research in Health (RETICS), Spain RD16/0017/0003
the Ministry of Science, Innovation and Universities, Carlos III Health Institute (ISCIII), European Fund for Regional Development (FEDER), Network for Cooperative Research in Health (RETICS), Spain PI17/00174
the Ministry of Science, Innovation and Universities, Carlos III Health Institute (ISCIII), European Fund for Regional Development (FEDER), Network for Cooperative Research in Health (RETICS), Spain INT19/00026
the Ministry of Science, Innovation and Universities, Carlos III Health Institute (ISCIII), European Fund for Regional Development (FEDER), Network for Cooperative Research in Health (RETICS), Spain CD19/00019
the Ministry of Health, National Plan on Drugs (PNSD), Spain 2018/020
the European Commission (806996-JUSTSO-JUST2017-AG-DRUG)
the Gilead Fellowship Program, Gilead Sciences GLD17/187
the Ministry of Education, Spain PRX18/00245
the Agency for Management of University and Research Grants, Government of Catalonia 2017SGR316
the Municipal Institute of Personal Services-IMSP, Badalona
Corresponding Author Robert Muga, MD, PhD, Professor, Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Ctra. canyet s/n, Badalona 08916, Spain. rmuga.germanstrias@gencat.cat
Key Words Direct-acting antiviral agents; Opioid Treatment Program; Opioid agonist therapy; Hepatitis C virus infection; Human immunodeficiency virus infection; Drug use
Core Tip Longitudinal study carried out in the only Opioid Treatment Program authorized for the provision of methadone or buprenorphine in a large urban area of 360000 inhabitants. Results indicate that hepatitis C virus treatment rates are increasing since the introduction of direct antiviral agents and identifies gaps and challenges on the readiness to treat infection.
Publish Date 2020-10-14 11:33
Citation Sanvisens A, Rivas I, Faure E, Espinach N, Hernandez-Rubio A, Majó X, Colom J, Muga R. Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study. World J Gastroenterol 2020; 26(38): 5874-5883
URL https://www.wjgnet.com/1007-9327/full/v26/i38/5874.htm
DOI https://dx.doi.org/10.3748/wjg.v26.i38.5874
Full Article (PDF) WJG-26-5874.pdf
Full Article (Word) WJG-26-5874.docx
STROBE Statement 57229-STROBE-Statement-revision.pdf
Manuscript File 57229-Review.docx
Answering Reviewers 57229-Answering reviewers.pdf
Audio Core Tip 57229-Audio core tip.opus
Biostatistics Review Certificate 57229-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 57229-Conflict-of-interest statement.pdf
Copyright License Agreement 57229-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 57229-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s) 57229-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 57229-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 57229-Language certificate.pdf
Peer-review Report 57229-Peer-review(s).pdf
Scientific Misconduct Check 57229-Bing-Yan JP-1.png
Scientific Misconduct Check 57229-Scientific misconduct check.pdf
Scientific Editor Work List 57229-Scientific editor work list.pdf